Skip to main content
PMC home page
Journal of Psychiatry & Neuroscience : JPN logoLink to Journal of Psychiatry & Neuroscience : JPN
. 1996 Mar;21(2):123–127.

The role of estrogen in schizophrenia.

M V Seeman 1
PMCID: PMC1188751  PMID: 8820178

Abstract

This paper reviews 3 recent studies from different clinics correlating psychotic symptoms with phases of the menstrual cycle in women with schizophrenia. The aim of the paper is to focus on the estrogen protection hypothesis which would suggest that low estrogen phases correlate with more severe symptoms, and high estrogen phases correlate with less severe symptoms. Although the methodology of the 3 studies was different, the hypothesis was essentially upheld. High levels of estrogens protect against symptom exacerbations in women with schizophrenia. A corollary to this finding is that, for optimal efficacy and safety, neuroleptic doses could be reduced at certain times of the month and increased at others.

Full text

PDF
123

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AYD F. J., Jr A survey of drug-induced extrapyramidal reactions. JAMA. 1961 Mar 25;175:1054–1060. doi: 10.1001/jama.1961.03040120016004. [DOI] [PubMed] [Google Scholar]
  2. Angermeyer M. C., Goldstein J. M., Kuehn L. Gender differences in schizophrenia: rehospitalization and community survival. Psychol Med. 1989 May;19(2):365–382. doi: 10.1017/s0033291700012411. [DOI] [PubMed] [Google Scholar]
  3. Bedard P., Langelier P., Villeneuve A. Oestrogens and extrapyramidal system. Lancet. 1977 Dec 24;2(8052-8053):1367–1368. doi: 10.1016/s0140-6736(77)90429-9. [DOI] [PubMed] [Google Scholar]
  4. Biehl H., Maurer K., Schubart C., Krumm B., Jung E. Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. Results of a prospective 5-year follow-up study. Eur Arch Psychiatry Neurol Sci. 1986;236(3):139–147. doi: 10.1007/BF00380941. [DOI] [PubMed] [Google Scholar]
  5. Bromet E., Harrow M., Kasl S. Premorbid functioning and outcome in schizophrenics and nonschizophrenics. Arch Gen Psychiatry. 1974 Feb;30(2):203–207. doi: 10.1001/archpsyc.1974.01760080061010. [DOI] [PubMed] [Google Scholar]
  6. Castle D. J., Wessely S., Murray R. M. Sex and schizophrenia: effects of diagnostic stringency, and associations with and premorbid variables. Br J Psychiatry. 1993 May;162:658–664. doi: 10.1192/bjp.162.5.658. [DOI] [PubMed] [Google Scholar]
  7. Chakos M. H., Mayerhoff D. I., Loebel A. D., Alvir J. M., Lieberman J. A. Incidence and correlates of acute extrapyramidal symptoms in first episode of schizophrenia. Psychopharmacol Bull. 1992;28(1):81–86. [PubMed] [Google Scholar]
  8. Chang S. S., Renshaw D. C. Psychosis and pregnancy. Compr Ther. 1986 Oct;12(10):36–41. [PubMed] [Google Scholar]
  9. Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev Neurosci. 1994 Jan-Mar;5(1):27–41. doi: 10.1515/revneuro.1994.5.1.27. [DOI] [PubMed] [Google Scholar]
  10. Dworkin R. H. Patterns of sex differences in negative symptoms and social functioning consistent with separate dimensions of schizophrenic psychopathology. Am J Psychiatry. 1990 Mar;147(3):347–349. doi: 10.1176/ajp.147.3.347. [DOI] [PubMed] [Google Scholar]
  11. Franzek E., Beckmann H. Sex differences and distinct subgroups in schizophrenia. A study of 54 chronic hospitalized schizophrenics. Psychopathology. 1992;25(2):90–99. doi: 10.1159/000284758. [DOI] [PubMed] [Google Scholar]
  12. Galdos P. M., van Os J. J., Murray R. M. Puberty and the onset of psychosis. Schizophr Res. 1993 Jun;10(1):7–14. doi: 10.1016/0920-9964(93)90071-p. [DOI] [PubMed] [Google Scholar]
  13. Gattaz W. F., Vogel P., Riecher-Rössler A., Soddu G. Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol Psychiatry. 1994 Jul 15;36(2):137–139. doi: 10.1016/0006-3223(94)91195-9. [DOI] [PubMed] [Google Scholar]
  14. Goldstein J. M., Faraone S. V., Chen W. J., Tolomiczencko G. S., Tsuang M. T. Sex differences in the familial transmission of schizophrenia. Br J Psychiatry. 1990 Jun;156:819–826. doi: 10.1192/bjp.156.6.819. [DOI] [PubMed] [Google Scholar]
  15. Goldstein J. M., Faraone S. V., Chen W. J., Tsuang M. T. Gender and the familial risk for schizophrenia. Disentangling confounding factors. Schizophr Res. 1992 Jul;7(2):135–140. doi: 10.1016/0920-9964(92)90043-5. [DOI] [PubMed] [Google Scholar]
  16. Goldstein J. M. Gender differences in the course of schizophrenia. Am J Psychiatry. 1988 Jun;145(6):684–689. doi: 10.1176/ajp.145.6.684. [DOI] [PubMed] [Google Scholar]
  17. Goldstein J. M., Link B. G. Gender and the expression of schizophrenia. J Psychiatr Res. 1988;22(2):141–155. doi: 10.1016/0022-3956(88)90078-7. [DOI] [PubMed] [Google Scholar]
  18. Hallonquist J. D., Seeman M. V., Lang M., Rector N. A. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry. 1993 Feb 1;33(3):207–209. doi: 10.1016/0006-3223(93)90141-y. [DOI] [PubMed] [Google Scholar]
  19. Hambrecht M., Maurer K., Häfner H. Evidence for a gender bias in epidemiological studies of schizophrenia. Schizophr Res. 1993 Jan;8(3):223–231. doi: 10.1016/0920-9964(93)90020-j. [DOI] [PubMed] [Google Scholar]
  20. Häfner H., Behrens S., De Vry J., Gattaz W. F. An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Res. 1991 Aug;38(2):125–134. doi: 10.1016/0165-1781(91)90038-q. [DOI] [PubMed] [Google Scholar]
  21. Häfner H., Maurer K., Löffler W., Riecher-Rössler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry. 1993 Jan;162:80–86. doi: 10.1192/bjp.162.1.80. [DOI] [PubMed] [Google Scholar]
  22. Häfner H., Riecher A., Maurer K., Löffler W., Munk-Jørgensen P., Strömgren E. How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol Med. 1989 Nov;19(4):903–918. doi: 10.1017/s0033291700005626. [DOI] [PubMed] [Google Scholar]
  23. Jonsson H., Nyman A. K. Predicting long-term outcome in schizophrenia. Acta Psychiatr Scand. 1991 May;83(5):342–346. doi: 10.1111/j.1600-0447.1991.tb05553.x. [DOI] [PubMed] [Google Scholar]
  24. Kendell R. E., Chalmers J. C., Platz C. Epidemiology of puerperal psychoses. Br J Psychiatry. 1987 May;150:662–673. doi: 10.1192/bjp.150.5.662. [DOI] [PubMed] [Google Scholar]
  25. Leff J., Sartorius N., Jablensky A., Korten A., Ernberg G. The International Pilot Study of Schizophrenia: five-year follow-up findings. Psychol Med. 1992 Feb;22(1):131–145. doi: 10.1017/s0033291700032797. [DOI] [PubMed] [Google Scholar]
  26. Lewis S. Sex and schizophrenia: vive la différence. Br J Psychiatry. 1992 Oct;161:445–450. doi: 10.1192/bjp.161.4.445. [DOI] [PubMed] [Google Scholar]
  27. Lieberman J., Bogerts B., Degreef G., Ashtari M., Lantos G., Alvir J. Qualitative assessment of brain morphology in acute and chronic schizophrenia. Am J Psychiatry. 1992 Jun;149(6):784–794. doi: 10.1176/ajp.149.6.784. [DOI] [PubMed] [Google Scholar]
  28. Loyd D., Simpson J. C., Tsuang M. T. Are there sex differences in the long-term outcome of schizophrenia? Comparisons with mania, depression, and surgical controls. J Nerv Ment Dis. 1985 Nov;173(11):643–649. doi: 10.1097/00005053-198511000-00001. [DOI] [PubMed] [Google Scholar]
  29. Luggin R., Bernsted L., Petersson B., Jacobsen A. T. Acute psychiatric admission related to the menstrual cycle. Acta Psychiatr Scand. 1984 Jun;69(6):461–465. doi: 10.1111/j.1600-0447.1984.tb02520.x. [DOI] [PubMed] [Google Scholar]
  30. Maier W., Lichtermann D., Minges J., Heun R., Hallmayer J. The impact of gender and age at onset on the familial aggregation of schizophrenia. Eur Arch Psychiatry Clin Neurosci. 1993;242(5):279–285. doi: 10.1007/BF02190387. [DOI] [PubMed] [Google Scholar]
  31. McCreadie R. G., Robertson L. J., Wiles D. H. The Nithsdale schizophrenia surveys. IX: Akathisia, parkinsonism, tardive dyskinesia and plasma neuroleptic levels. Br J Psychiatry. 1992 Jun;160:793–799. doi: 10.1192/bjp.160.6.793. [DOI] [PubMed] [Google Scholar]
  32. McEwen B. S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci. 1991 Apr;12(4):141–147. doi: 10.1016/0165-6147(91)90531-v. [DOI] [PubMed] [Google Scholar]
  33. McNiel D. E., Greenfield T. K., Attkisson C. C., Binder R. L. Factor structure of a brief symptom checklist for acute psychiatric inpatients. J Clin Psychol. 1989 Jan;45(1):66–72. doi: 10.1002/1097-4679(198901)45:1<66::aid-jclp2270450109>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  34. Nedopil N., Pflieger R., Rüther E. The prediction of acute response, remission and general outcome of neuroleptic treatment in acute schizophrenic patients. Pharmacopsychiatria. 1983 Nov;16(6):201–205. doi: 10.1055/s-2007-1019499. [DOI] [PubMed] [Google Scholar]
  35. Opjordsmoen S. Long-term clinical outcome of schizophrenia with special reference to gender differences. Acta Psychiatr Scand. 1991 Apr;83(4):307–313. doi: 10.1111/j.1600-0447.1991.tb05545.x. [DOI] [PubMed] [Google Scholar]
  36. Prudo R., Blum H. M. Five-year outcome and prognosis in schizophrenia: a report from the London Field Research Centre of the International Pilot Study of Schizophrenia. Br J Psychiatry. 1987 Mar;150:345–354. doi: 10.1192/bjp.150.3.345. [DOI] [PubMed] [Google Scholar]
  37. Rector N. A., Seeman M. V. Auditory hallucinations in women and men. Schizophr Res. 1992 Sep;7(3):233–236. doi: 10.1016/0920-9964(92)90017-y. [DOI] [PubMed] [Google Scholar]
  38. Riecher-Rössler A., Häfner H. Schizophrenia and oestrogens--is there an association? Eur Arch Psychiatry Clin Neurosci. 1993;242(6):323–328. doi: 10.1007/BF02190244. [DOI] [PubMed] [Google Scholar]
  39. Riecher-Rössler A., Häfner H., Stumbaum M., Maurer K., Schmidt R. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull. 1994;20(1):203–214. doi: 10.1093/schbul/20.1.203. [DOI] [PubMed] [Google Scholar]
  40. Rubinow D. R., Roy-Byrne P. Premenstrual syndromes: overview from a methodologic perspective. Am J Psychiatry. 1984 Feb;141(2):163–172. doi: 10.1176/ajp.141.2.163. [DOI] [PubMed] [Google Scholar]
  41. Salokangas R. K., Stengård E. Gender and short-term outcome in schizophrenia. Schizophr Res. 1990 Oct-Dec;3(5-6):333–345. doi: 10.1016/0920-9964(90)90019-4. [DOI] [PubMed] [Google Scholar]
  42. Seeman M. V. Interaction of sex, age, and neuroleptic dose. Compr Psychiatry. 1983 Mar-Apr;24(2):125–128. doi: 10.1016/0010-440x(83)90100-1. [DOI] [PubMed] [Google Scholar]
  43. Seeman M. V., Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull. 1990;16(2):185–194. doi: 10.1093/schbul/16.2.185. [DOI] [PubMed] [Google Scholar]
  44. Shtasel D. L., Gur R. E., Gallacher F., Heimberg C., Gur R. C. Gender differences in the clinical expression of schizophrenia. Schizophr Res. 1992 Sep;7(3):225–231. doi: 10.1016/0920-9964(92)90016-x. [DOI] [PubMed] [Google Scholar]
  45. Swett C., Jr Drug-induced dystonia. Am J Psychiatry. 1975 May;132(5):532–534. doi: 10.1176/ajp.132.5.532. [DOI] [PubMed] [Google Scholar]
  46. Takei N., O'Callaghan E., Sham P. C., Glover G., Murray R. M. Does prenatal influenza divert susceptible females from later affective psychosis to schizophrenia? Acta Psychiatr Scand. 1993 Nov;88(5):328–336. doi: 10.1111/j.1600-0447.1993.tb03468.x. [DOI] [PubMed] [Google Scholar]
  47. Takei N., Sham P., O'Callaghan E., Murray G. K., Glover G., Murray R. M. Prenatal exposure to influenza and the development of schizophrenia: is the effect confined to females? Am J Psychiatry. 1994 Jan;151(1):117–119. doi: 10.1176/ajp.151.1.117. [DOI] [PubMed] [Google Scholar]
  48. Thara R., Rajkumar S. Gender differences in schizophrenia. Results of a follow-up study from India. Schizophr Res. 1992 Apr;7(1):65–70. doi: 10.1016/0920-9964(92)90075-g. [DOI] [PubMed] [Google Scholar]
  49. Villeneuve A., Cazejust T., Côté M. Estrogens in tardive dyskinesia in male psychiatric patients. Neuropsychobiology. 1980;6(3):145–151. doi: 10.1159/000117746. [DOI] [PubMed] [Google Scholar]
  50. Wolyniec P. S., Pulver A. E., McGrath J. A., Tam D. Schizophrenia: gender and familial risk. J Psychiatr Res. 1992 Jan;26(1):17–27. doi: 10.1016/0022-3956(92)90012-d. [DOI] [PubMed] [Google Scholar]
  51. Yassa R., Jeste D. V. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull. 1992;18(4):701–715. doi: 10.1093/schbul/18.4.701. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Medical Association

RESOURCES